MaxCyte, Inc. (MXCT)
USD 2.47
(-5.19%)
USD 2.47
(-5.19%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 36.1 Million USD | 10.47% |
| 2022 | 32.68 Million USD | 54.01% |
| 2021 | 21.22 Million USD | 14.38% |
| 2020 | 18.55 Million USD | 13.25% |
| 2019 | 16.38 Million USD | 36.69% |
| 2018 | 11.98 Million USD | 1.57% |
| 2017 | 11.8 Million USD | 7.39% |
| 2016 | 10.98 Million USD | 15.87% |
| 2015 | 9.48 Million USD | 19.31% |
| 2014 | 7.94 Million USD | 96.37% |
| 2013 | 4.04 Million USD | 17.92% |
| 2012 | 3.43 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 30.23 Million USD | -4.23% |
| 2024 Q1 | 31.57 Million USD | -12.56% |
| 2023 Q2 | 30.22 Million USD | -10.39% |
| 2023 Q4 | 36.1 Million USD | 8.26% |
| 2023 FY | 36.1 Million USD | 10.47% |
| 2023 Q3 | 33.35 Million USD | 10.35% |
| 2023 Q1 | 33.72 Million USD | 3.18% |
| 2022 Q3 | 31.97 Million USD | -1.76% |
| 2022 Q4 | 32.68 Million USD | 2.21% |
| 2022 Q1 | 28.77 Million USD | 35.56% |
| 2022 Q2 | 32.55 Million USD | 13.15% |
| 2022 FY | 32.68 Million USD | 54.01% |
| 2021 Q4 | 21.22 Million USD | 56.35% |
| 2021 Q2 | 14.32 Million USD | 4.4% |
| 2021 Q1 | 13.72 Million USD | -26.04% |
| 2021 Q3 | 13.57 Million USD | -5.25% |
| 2021 FY | 21.22 Million USD | 14.38% |
| 2020 Q4 | 18.55 Million USD | 0.0% |
| 2020 FY | 18.55 Million USD | 13.25% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q2 | 16.16 Million USD | 0.0% |
| 2019 Q1 | 8.37 Million USD | -30.1% |
| 2019 Q4 | 16.38 Million USD | 0.0% |
| 2019 Q3 | 16.38 Million USD | 88.46% |
| 2019 FY | 16.38 Million USD | 36.69% |
| 2019 Q2 | 8.69 Million USD | 3.76% |
| 2018 Q1 | 11.41 Million USD | -3.24% |
| 2018 Q2 | 11.41 Million USD | 0.0% |
| 2018 FY | 11.98 Million USD | 1.57% |
| 2018 Q3 | 11.98 Million USD | 4.97% |
| 2018 Q4 | 11.98 Million USD | 0.0% |
| 2017 Q1 | 12.15 Million USD | 10.6% |
| 2017 FY | 11.8 Million USD | 7.39% |
| 2017 Q4 | 11.8 Million USD | 0.0% |
| 2017 Q3 | 11.8 Million USD | -2.9% |
| 2017 Q2 | 12.15 Million USD | 0.0% |
| 2016 Q1 | 9.35 Million USD | -1.37% |
| 2016 Q4 | 10.98 Million USD | 0.0% |
| 2016 FY | 10.98 Million USD | 15.87% |
| 2016 Q3 | 10.98 Million USD | 17.48% |
| 2016 Q2 | 9.35 Million USD | 0.0% |
| 2015 Q3 | 9.39 Million USD | 11.62% |
| 2015 Q1 | 8.41 Million USD | 5.93% |
| 2015 FY | 9.48 Million USD | 19.31% |
| 2015 Q4 | 9.48 Million USD | 0.91% |
| 2015 Q2 | 8.41 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | 7.94 Million USD | 2.91% |
| 2014 Q3 | 7.72 Million USD | 0.0% |
| 2014 FY | 7.94 Million USD | 96.37% |
| 2013 FY | 4.04 Million USD | 17.92% |
| 2012 FY | 3.43 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 29.553% |
| BrainsWay Ltd. | 15.31 Million USD | -135.778% |
| Cerus Corporation | 144.3 Million USD | 74.979% |
| Envoy Medical, Inc. | 9.4 Million USD | -284.035% |
| electroCore, Inc. | 8.94 Million USD | -303.656% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -575.908% |
| IceCure Medical Ltd | 4.24 Million USD | -750.177% |
| Inogen, Inc. | 121.38 Million USD | 70.253% |
| OrthoPediatrics Corp. | 72.56 Million USD | 50.239% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -22.061% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1034.747% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -1853.937% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -8390.151% |
| Orthofix Medical Inc. | 326.58 Million USD | 88.944% |
| PAVmed Inc | 57.13 Million USD | 36.806% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -41.802% |
| RxSight, Inc. | 22.18 Million USD | -62.732% |
| Sight Sciences, Inc. | 46.43 Million USD | 22.244% |
| SI-BONE, Inc. | 61.05 Million USD | 40.857% |
| TELA Bio, Inc. | 59.16 Million USD | 38.974% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 68.319% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -249.908% |
| Acutus Medical, Inc. | 54.83 Million USD | 34.158% |
| Talis Biomedical Corporation | 29.22 Million USD | -23.553% |
| Spectral AI, Inc. | 12.4 Million USD | -191.162% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -56.078% |
| CVRx, Inc. | 39.28 Million USD | 8.083% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -201.947% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1386.313% |
| Bioventus Inc. | 589.79 Million USD | 93.878% |
| Venus Concept Inc. | 107.1 Million USD | 66.288% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 30.111% |
| LivaNova PLC | 1.15 Billion USD | 96.866% |
| 908 Devices Inc. | 37.49 Million USD | 3.689% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 94.867% |
| Nemaura Medical Inc. | 26.37 Million USD | -36.886% |
| NeuroPace, Inc. | 86.99 Million USD | 58.496% |
| LENSAR, Inc. | 22.4 Million USD | -61.127% |
| Apyx Medical Corporation | 52.31 Million USD | 30.986% |
| Cutera, Inc. | 518.12 Million USD | 93.031% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -23.114% |
| BioSig Technologies, Inc. | 4.68 Million USD | -670.694% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 38.138% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -68.033% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.354% |
| Axonics, Inc. | 82.35 Million USD | 56.159% |
| Outset Medical, Inc. | 190.91 Million USD | 81.087% |
| IRIDEX Corporation | 24.91 Million USD | -44.927% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 70.873% |
| IRadimed Corporation | 20.73 Million USD | -74.128% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -2056.93% |
| INVO Bioscience, Inc. | 19.99 Million USD | -80.58% |
| Telesis Bio, Inc. | 40.87 Million USD | 11.661% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 11.481% |
| Varex Imaging Corporation | 668.6 Million USD | 94.6% |
| Quipt Home Medical Corp. | 136.29 Million USD | 73.508% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -910.834% |
| Pulmonx Corporation | 60.63 Million USD | 40.453% |
| Dynatronics Corporation | 11.78 Million USD | -206.508% |
| Modular Medical, Inc. | 2.27 Million USD | -1489.217% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -788.46% |
| Semler Scientific, Inc. | 6.27 Million USD | -475.869% |
| InMode Ltd. | 75.91 Million USD | 52.437% |
| Bruker Corporation | 2.83 Billion USD | 98.727% |
| Cytosorbents Corporation | 29.98 Million USD | -20.415% |
| DexCom, Inc. | 4.19 Billion USD | 99.139% |
| Align Technology, Inc. | 2.45 Billion USD | 98.528% |
| Viveve Medical, Inc. | 10.84 Million USD | -232.875% |
| ZimVie Inc. | 795.85 Million USD | 95.463% |
| Movano Inc. | 5.97 Million USD | -504.605% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 65.483% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -8390.151% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -201.947% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 94.35% |
| Profound Medical Corp. | 12.66 Million USD | -185.073% |
| Insulet Corporation | 1.85 Billion USD | 98.054% |
| enVVeno Medical Corporation | 2.43 Million USD | -1382.834% |
| Surmodics, Inc. | 65.82 Million USD | 45.145% |
| iCAD, Inc. | 8 Million USD | -351.281% |
| Nuwellis, Inc. | 6.78 Million USD | -432.552% |
| Biotricity, Inc. | 35.91 Million USD | -0.522% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 83.812% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1356.133% |
| InspireMD, Inc. | 8.14 Million USD | -343.466% |
| PAVmed Inc. | 57.13 Million USD | 36.806% |
| BIOLASE, Inc. | 35.34 Million USD | -2.147% |
| Beyond Air, Inc. | 29.77 Million USD | -21.266% |
| FONAR Corporation | 57.45 Million USD | 37.159% |
| AxoGen, Inc. | 101.16 Million USD | 64.308% |
| Vivani Medical, Inc. | 25.03 Million USD | -44.22% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 58.874% |
| Inari Medical, Inc. | 209.32 Million USD | 82.751% |
| UFP Technologies, Inc. | 118.04 Million USD | 69.413% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -184.52% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1551.88% |
| Tenon Medical, Inc. | 5.56 Million USD | -548.59% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -1929.623% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -104.757% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.855% |
| Sintx Technologies, Inc. | 6.59 Million USD | -447.657% |
| NanoVibronix, Inc. | 2.68 Million USD | -1244.267% |
| Quanterix Corporation | 78.08 Million USD | 53.759% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -910.834% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -639.14% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 96.544% |
| TransMedics Group, Inc. | 568.84 Million USD | 93.653% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -116.443% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2608.45% |
| Hyperfine, Inc. | 9.8 Million USD | -268.439% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 85.571% |
| Biomerica, Inc. | 2.66 Million USD | -1255.877% |
| Bone Biologics Corporation | 831.4 Thousand USD | -4242.905% |
| AVITA Medical, Inc. | 19.86 Million USD | -81.758% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1729.422% |
| Silk Road Medical, Inc | 114.15 Million USD | 68.371% |